- Filed
- Nov 7, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · Nov 6, 2023 | 97.52M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 96.88M sh |
| Shares Diluted restated | Q1 2023 · Mar 31, 2022 | 95.71M sh |
| Capex | Q1 2023 · Mar 31, 2023 | $600K |
| Capex | Q1 2023 · Mar 31, 2022 | $2.12M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$11M |
| Operating Cash Flow restated | Q1 2023 · Mar 31, 2022 | −$45.83M |
| Long Term Debt | Q1 2023 · Mar 31, 2023 | $125.06M |
| Long Term Debt | Q1 2023 · Dec 31, 2022 | $88.34M |
| Short Term Debt | Q1 2023 · Mar 31, 2023 | $2.1M |
| Short Term Debt | Q1 2023 · Dec 31, 2022 | $106K |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $53.73M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $5.27M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2022 | $13.99M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2021 | $42M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | −$62.8M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | −$42.91M |
| Stockholders Equity restated | Q1 2023 · Mar 31, 2022 | $104.07M |
| Stockholders Equity restated | Q1 2023 · Dec 31, 2021 | $120.07M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $69.11M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $72.57M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $242.88M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $185.62M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $116.15M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $75.44M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $180.08M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $142.71M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.23 |
| Eps Diluted restated | Q1 2023 · Mar 31, 2022 | −$0.10 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.23 |
| Eps Basic restated | Q1 2023 · Mar 31, 2022 | −$0.10 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $31.5M |
| Sga Expense restated | Q1 2023 · Mar 31, 2022 | $32.12M |
| Net Income | Q1 2023 · Mar 31, 2023 | −$22.65M |
| Net Income restated | Q1 2023 · Mar 31, 2022 | −$9.48M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$19.78M |
| Operating Income restated | Q1 2023 · Mar 31, 2022 | −$11.15M |
| Gross Profit | Q1 2023 · Mar 31, 2023 | $11.73M |
| Gross Profit restated | Q1 2023 · Mar 31, 2022 | $20.97M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2023 | $5.85M |
| Cost Of Revenue restated | Q1 2023 · Mar 31, 2022 | $8.42M |
| Revenue | Q1 2023 · Mar 31, 2023 | $17.58M |
| Revenue restated | Q1 2023 · Mar 31, 2022 | $29.39M |